The use of two plasma derived factor VIII concentrates in type 2 a von Willebrand's disease (VWD).

被引：0
|
作者：
Hampton, KK [1 ]
Makris, M [1 ]
机构：
[1] Univ Sheffield, Sheffield S10 2TN, S Yorkshire, England
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4103
引用
收藏
页码：99B / 99B
页数：1
相关论文
共 50 条
  • [21] PLATELET-FACTOR-VIII-VON WILLEBRAND FACTOR (VIII-VWF) BINDING IN VARIANT VON WILLEBRANDS DISEASE (VWD)
    CASTELLA, A
    MILLER, JL
    FEDERATION PROCEEDINGS, 1982, 41 (03) : 700 - 700
  • [22] Factor VIII as a screening test for von Willebrand's disease: Is there a level at which VWD becomes unlikely?
    McHugh, C
    Velleca, M
    McPhedran, P
    Clyne, LP
    BLOOD, 1995, 86 (10) : 3513 - 3513
  • [23] Hemostatic management of von Willebrand disease during childbirth with a plasma-derived von Willebrand factor/ factor VIII concentrate
    Iorio, Alfonso
    James, Paula
    Ma, Alice
    Srivastava, Alok
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2024, 22 (10) : 2739 - 2744
  • [24] Expression studies of von Willebrand factor missense mutations causing type 1 or type 2 von Willebrand disease (VWD)
    Yadegari, H.
    Driesen, J.
    Hambitzer, P.
    Pavlova, A.
    Oldenburg, J.
    HAEMOPHILIA, 2012, 18 : 195 - 196
  • [25] Von Willebrand Factor (VWF) multiplex activity assay differentiation of type 1 von Willebrand Disease (VWD) and variant VWD
    Roberts, Jonathan C.
    Christopherson, Pamela A.
    Tarantino, Michael D.
    Gonzales, Sarah E.
    Morateck, Patti A.
    Perry, Crystal L.
    Flood, Veronica H.
    Abshire, Thomas C.
    Montgomery, Robert R.
    HAEMOPHILIA, 2024, 30 (01) : 161 - 168
  • [26] Management of von Willebrand disease with factor VIII/von Willebrand factor concentrates: results from current studies and surveys
    Federici, AB
    BLOOD COAGULATION & FIBRINOLYSIS, 2005, 16 : S17 - S21
  • [27] Comparative analysis and classification of von Willebrand factor/factor VIII concentrates:: Impact on treatment of patients with von Willebrand disease
    Budde, Ulrich
    Metzner, Hubert J.
    Mueller, Heinz-Georg
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2006, 32 (06): : 626 - 635
  • [28] Use of objective efficacy criteria for evaluation of von willebrand factor/factor VIII concentrates
    Kessler, Craig M.
    Windyga, Jerzy
    Schwartz, Bruce A.
    Knaub, Sigurd
    BLOOD COAGULATION & FIBRINOLYSIS, 2012, 23 (04) : 262 - 267
  • [29] Pharmacokinetic analysis of a von Willebrand factor/factor VIII (VWF/FVIII) concentrate in adults-and children with von Willebrand disease (VWD)
    Di Paola, Jorge
    Lethagen, Stephan
    Gill, Joan
    Mannucci, Pier
    Bemstein, Jonathan
    Nichols, William
    Friedman, Carl
    Knaub, Sigurd
    Bergman, Garrett
    BLOOD, 2007, 110 (11) : 637A - 637A
  • [30] Undetected factor VIII level in a type III von Willebrand disease (vWD) patient masquerading as severe hemophilia
    Mullah-Ali, AM
    Chan, A
    Pai, MK
    Decker, K
    Moffat, KA
    Walker, I
    BLOOD, 2005, 106 (11) : 104B - 104B
12345